At the Conversational AI and Customer Experience summit last week, PB Fintech President, Rajiv Gupta stated how AI systems are being put into use to drive progress in the health insurance sector of the country

The Central Drugs Standard Control Organization (CDSCO) has recently released a document on Good Distribution Practices (GDP) that concerns all pharmaceutical products being sold in India.

Pharmaceutical manufacturers are now permitted to adjust the Maximum Retail Price (MRP) of scheduled drug formulations in line with the recent Wholesale Price Index (WPI) change of 0.00551% independently without government’s approval.

Physicians have blamed lack of standardization as the cause for not prescribing generics to patients. Sources from the medical community informed India Pharma Outlook that the quality and efficacy of generic medicines are the primary reasons why

Research conducted by India Pharma Outlook revealed that many physicians have been bribed for decades to prescribe specific medicines and, in an extended number of cases oncologists have been bribed to validate clinical trials of certain drugs.